Amicus Therapeutics, Inc.

FOLD · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$213,752$246,994$148,813$245,197
Short-Term Investments$36,194$39,206$144,782$237,299
Receivables$101,099$87,632$66,196$52,672
Inventory$118,782$59,696$23,816$26,818
Other Curr. Assets$34,909$49,533$40,209$34,848
Total Curr. Assets$504,736$483,061$423,816$596,834
Property Plant & Equip (Net)$51,661$57,979$60,312$63,082
Goodwill$197,797$197,797$197,797$197,797
Intangibles$17,198$20,490$23,000$23,000
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$13,641$18,553$19,242$24,427
Total NC Assets$280,297$294,819$300,351$308,306
Other Assets$0$0$0$0
Total Assets$785,033$777,880$724,167$905,140
Liabilities
Payables$12,947$15,120$15,413$21,513
Short-Term Debt$8,455$8,324$8,552$7,409
Tax Payable$18,105$12,434$5,938$6,154
Deferred Revenue$0$0$0$0
Other Curr. Liab.$109,195$131,811$109,115$110,899
Total Curr. Liab.$148,702$167,689$139,018$145,975
LT Debt$435,189$436,735$443,568$432,720
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$4,939$4,930
Other NC Liab.$7,097$13,282$13,595$14,146
Total NC Liab.$442,286$450,017$462,102$451,796
Other Liabilities$0$0$0$0
Cap. Leases$53,533$57,201$60,130$50,772
Total Liabilities$590,988$617,706$601,120$597,771
Equity
Pref Stock$0$0$0$0
Common Stock$2,944$2,918$2,815$2,808
Retained Earnings-$2,740,180-$2,684,074-$2,532,490-$2,295,922
AOCI$5,095$5,241-$12,105$4,981
Other Equity$2,926,186$2,836,089$2,664,827$2,595,502
Total Equity$194,045$160,174$123,047$307,369
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$785,033$777,880$724,167$905,140
Net Debt$229,892$198,065$303,307$194,932
Amicus Therapeutics, Inc. (FOLD) Financial Statements & Key Stats | AlphaPilot